Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Original Research

Published on 28 Mar 2025

Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study

in Lipids in Cardiovascular Disease

Jia-Le Chen
Xin-Yi Lu
Dao-Zhen Chen
Yu Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1445732

136 views

Original Research

Accepted on 27 Mar 2025

Lipid-lowering therapy (LLT) in 1,100 cardiac rehabilitation patients with coronary heart disease: The LLT-R(ehabilitation) registry

in Lipids in Cardiovascular Disease

Frank Noack
Kristina Eckrich
Heinz Völler
Bernhard Schwaab
Viktoria Heinze
Christa Bongarth
Manju Guha
Michael Richter
Nadja Schwark
Alexandra Strobel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1549935

Original Research

Accepted on 26 Mar 2025

A clinical study into the impact of brief aerobic exercise on the cardiopulmonary function of patients diagnosed with hyperlipidemia

in Lipids in Cardiovascular Disease

Hua Zhang
Ning Wang
Ya-Ru Ge
Li Feng
Xiao-Yan Zhang
Cong Liu
Jing Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1484693

Brief Research Report

Published on 20 Mar 2025

Unveiling patient profiles associated with elevated Lp(a) through an unbiased clustering analysis

in Lipids in Cardiovascular Disease

Miguel Saraiva
Jonatas Garcez
Beatriz Tavares da Silva
Inês Poças Ferreira
José Carlos Oliveira
Isabel Palma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1546351

571 views

Original Research

Accepted on 18 Mar 2025

Lipid and Immunophenotypic Profiles in Hemodialysis Patients with Citrate vs. Acetate Dialysates

in Lipids in Cardiovascular Disease

Diana Rodríguez-Espinosa
Elena Cuadrado-Payán
Laura Morantes
Miquel Gomez
Francisco Maduell
José Jesús Broseta

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1497353

Original Research

Published on 10 Mar 2025

Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease

in Lipids in Cardiovascular Disease

Yu Li
Yumei Zhai
Songli Hu
Jing Liu
Wenchen Zhang
Jianwei Yue
Zichao Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1516326

484 views

Review

Published on 03 Mar 2025

Crosstalk between lipid metabolism and macrophages in atherosclerosis: therapeutic potential of natural products

in Lipids in Cardiovascular Disease

Taoming Qian
Donghao Guo
Lu Sun
Ming Chi
Xiaoshuang Ma
Juan Jin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1529924

505 views

Opinion

Published on 27 Feb 2025

Fatigued with Friedewald: why isn't everyone onboard yet with the new LDL-C equations?

in Lipids in Cardiovascular Disease

Madhusudhanan Narasimhan
Jing Cao
Jeffrey W. Meeusen
Alan T. Remaley
Seth S. Martin
Alagarraju Muthukumar

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1534460

769 views

Original Research

Published on 19 Feb 2025

Dietary and lifestyle oxidative balance scores and their impact on cardiovascular diseases: exploring the mediating influence of hepatic function and blood lipid levels

in Lipids in Cardiovascular Disease

Yi He
Ying Lan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1493271

669 views

Brief Research Report

Published on 14 Feb 2025

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

in Lipids in Cardiovascular Disease

Wann Jia Loh
Jing Pang
Oliver Simon
Dick C. Chan
Gerald F. Watts

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1527351

647 views

Original Research

Published on 12 Feb 2025

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes

in Lipids in Cardiovascular Disease

Lulu Sun
Zhuo Wang
Bai Wang
Yuxiang Jia
Qidi Zhao
Jingjun Zhao
Xingtao Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1493613

469 views

Systematic Review

Published on 05 Feb 2025

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis

in Lipids in Cardiovascular Disease

Yuhua Jiang
Yingying Wang
Sijia Ma
Linlin Qian
Yeteng Jing
Xi Chen
Jinsheng Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1415668

1,502 views

Mini Review

Published on 05 Feb 2025

Call for a consensual definition of dyslipidemia in coronary angiography trials

in Lipids in Cardiovascular Disease

Aurélien Clerc
Mario Togni
Stephane Cook

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1506149

723 views

Editorial

Published on 23 Jan 2025

Editorial: Women in lipids in cardiovascular disease

in Lipids in Cardiovascular Disease

Irena Levitan
Catherine Martel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1547089

524 views

Original Research

Accepted on 10 Jan 2025

Association of accumulated exposure to non-high-density lipoprotein cholesterol concentration with risk of premature cardiovascular disease: the Kailuan Study

in Lipids in Cardiovascular Disease

Yifei Wang
Xuemei Zhao
Haibo Gao
Wei Li
Haotian Wu
Guiping Wang
Xiaokun Liu
Shouling Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1480566

Hypothesis and Theory

Published on 10 Jan 2025

U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999–2018

in Lipids in Cardiovascular Disease

Zi Lin
Tao Yi
Feng Hu
Jinhua Chen
Lianglong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1524465

1,017 views

Navigation group

Articles

Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study

Lipid-lowering therapy (LLT) in 1,100 cardiac rehabilitation patients with coronary heart disease: The LLT-R(ehabilitation) registry

A clinical study into the impact of brief aerobic exercise on the cardiopulmonary function of patients diagnosed with hyperlipidemia

Unveiling patient profiles associated with elevated Lp(a) through an unbiased clustering analysis

Lipid and Immunophenotypic Profiles in Hemodialysis Patients with Citrate vs. Acetate Dialysates

Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease

Crosstalk between lipid metabolism and macrophages in atherosclerosis: therapeutic potential of natural products

Fatigued with Friedewald: why isn't everyone onboard yet with the new LDL-C equations?

Dietary and lifestyle oxidative balance scores and their impact on cardiovascular diseases: exploring the mediating influence of hepatic function and blood lipid levels

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes

Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systematic network meta-analysis

Call for a consensual definition of dyslipidemia in coronary angiography trials

Editorial: Women in lipids in cardiovascular disease

Association of accumulated exposure to non-high-density lipoprotein cholesterol concentration with risk of premature cardiovascular disease: the Kailuan Study

U-shaped association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality risk in obese adults: evidence from NHANES 1999–2018